FASEB J.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published as doi: 10.1096/fj.07-083857.
(The FASEB Journal. 2008;22:1778-1789.)
© 2008 FASEB
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
fj.07-083857v1
22/6/1778    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Yu, H.
Right arrow Articles by Eickelberg, O.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yu, H.
Right arrow Articles by Eickelberg, O.

Transgelin is a direct target of TGF-β/Smad3-dependent epithelial cell migration in lung fibrosis

Haiying Yu*, Melanie Königshoff*, Aparna Jayachandran*, Dan Handley{dagger}, Werner Seeger*, Naftali Kaminski{dagger} and Oliver Eickelberg*,1

* Department of Medicine II, University of Giessen Lung Center, Justus Liebig University Giessen, Giessen, Germany; and

{dagger} Pulmonary, Allergy and Critical Care Medicine, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA

1Correspondence: University of Giessen Lung Center, Department of Medicine II, Aulweg 123, Rm. 6–11, D-35392 Giessen, Germany. E-mail: oliver.eickelberg{at}innere.med.uni-giessen.de

Enhanced transforming growth factor (TGF) -β signaling contributes to idiopathic pulmonary fibrosis (IPF), a progressive and fatal disease characterized by alveolar epithelial type II (ATII) cell hyperplasia, (myo)fibroblast accumulation, and excessive extracellular matrix deposition. TGF-β is a potent inducer of lung fibrosis, and it regulates the ATII cell phenotype; however, direct TGF-β target genes controlling the ATII cell phenotype remain elusive. Here, we identified the transgelin (tagln) gene as a novel immediate target of TGF-β/Smad3-dependent gene expression in ATII cells using a Smad3 chromatin immunoprecipitation (ChIP) screen. Direct ChIP confirmed the rapid and specific binding of Smad3 to the tagln promoter. Luciferase assays demonstrated transactivation of the tagln promoter by activin-like kinase (Alk) 5-mediated TGF-β signaling. TGF-β treatment resulted in rapid up-regulation of tagln, but not tagln2, mRNA and protein expression, assessed by reverse transcription-polymerase chain reaction (RT-PCR), Western blotting, and immunofluorescence. In vivo, tagln expression was significantly increased in ATII cells of mice during bleomycin-induced lung fibrosis, as well as in lung specimen obtained from IPF patients, as assessed by RT-PCR and immunohistochemistry. Knockdown of tagln using siRNA inhibited TGF-β-induced migration of lung epithelial A549 cells, as well as primary ATII cells. We thus identified tagln as a novel target of TGF-β/Smad3-dependent gene expression in ATII cells. Increased ATII cell expression of tagln in experimental and idiopathic pulmonary fibrosis may contribute to TGF-β-dependent ATII cell injury, repair, and migration in lung fibrosis.—Yu, H., Königshoff, M., Jayachandran, A., Handley, D., Seeger, W., Kaminski, N., Eickelberg, O. Transgelin is a direct target of TGF-β/Smad3-dependent epithelial cell migration in lung fibrosis.


Key Words: alveolar epithelial cell • signal transduction • bleomycin







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by The Federation of American Societies for Experimental Biology.